# US 8,277,833 B2 · Medical devices having surface coatings

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,833 B2
- Document ID: US8277833B2
- Status: Granted
- Kind: B2
- Application number: 12/489,996
- Filed: 2009-06-23
- Published: 2009-12-31
- Granted: 2012-10-02
- Earliest claimed: 2008-06-25
- Assignees: Boston Scientific Scimed, Inc.
- Inventors: Liliana Atanasoska; James Lee Shippy, III; Benjamin Arcand; Robert W. Warner
- Web page: https://patentgrep.com/patent/US8277833B2

## CPC

- A61L 31/022: {Metals or alloys}
- A61L 31/08: Materials for coatings
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

According to an aspect of the present invention, medical devices are provided which comprise a metallic region and a coating on all or part of the metallic region that comprises a multivalent acid.

## Claims

### Claim 1

An implantable or insertable medical device comprising a bioerodable metallic region and a bioerodable coating over at least a portion of the metallic region, wherein said coating comprises a multivalent acid comprising multiple phosphoric acid groups, and wherein said coating acts to slow or delay the in vivo degradation of the bioerodable metallic region in vivo.

### Claim 2 (depends on 1)

The implantable or insertable medical device of claim 1, wherein the bioerodable metallic region is selected from the group consisting of magnesium, zinc, iron, calcium, alloys that comprise magnesium, alloys that comprise zinc, alloys that comprise iron, and alloys that comprise calcium.

### Claim 3 (depends on 1)

The implantable or insertable medical device of claim 1, wherein said multivalent acid is phytic acid.

### Claim 4 (depends on 1)

The implantable or insertable medical device of claim 1, wherein said medical device is selected from the group consisting of stents and implantable electrical leads.

### Claim 5 (depends on 1)

The implantable or insertable medical device of claim 1, wherein said coating comprises a reaction product of phytic acid and the underlying metallic region.

### Claim 6 (depends on 1)

The implantable or insertable medical device of claim 1, wherein said coating further comprises ceramic particles.

### Claim 7 (depends on 6)

The implantable or insertable medical device of claim 6, wherein the ceramic particles comprise an oxide selected from the group consisting of oxides of magnesium, calcium, zinc, titanium, iron, aluminum, iridium and silicon.

### Claim 8 (depends on 6)

The implantable or insertable medical device of claim 6, further comprising a charged or uncharged therapeutic agent.

### Claim 9 (depends on 8)

The implantable or insertable medical device of claim 8, wherein said therapeutic agent is an antirestenotic agent or an angiogenesis inhibitor.

### Claim 10 (depends on 6)

The implantable or insertable medical device of claim 6, wherein said coating comprises alternating layers of phytic acid and said ceramic particles.

### Claim 11 (depends on 10)

The implantable or insertable medical device of claim 10, comprising at least three layers of phytic acid and at least three layers of said ceramic particles.

### Claim 12 (depends on 1)

The implantable or insertable medical device of claim 1, wherein said coating further comprises a charged polymer.

### Claim 13 (depends on 12)

The implantable or insertable medical device of claim 12, wherein said charged polymer has a positive net charge.

### Claim 14 (depends on 12)

The implantable or insertable medical device of claim 12, wherein said charged polymer comprises a poly(amino acid) sequence.

### Claim 15 (depends on 12)

The implantable or insertable medical device of claim 12, wherein said charged polymer promotes endothelialization.

### Claim 16 (depends on 12)

The implantable or insertable medical device of claim 12, wherein said coating further comprises ceramic particles.

### Claim 17 (depends on 1)

The implantable or insertable medical device of claim 1, wherein the coating thickness ranges between 100 nm and 10,000 nm.

### Claim 18 (depends on 1)

The implantable or insertable medical device of claim 1, wherein the coating is a multilayer coating.

### Claim 19 (depends on 18)

The implantable or insertable medical device of claim 18, wherein the coating comprises alternating layers of (a) the multivalent acid and (b) a species selected from the group consisting of ceramic particles, metallic particles, particles having a positive net charge, polymers comprising a poly(amino acid) sequence, polymers having a positive net charge, therapeutic agents having a positive net charge.

### Claim 20 (depends on 1)

The implantable or insertable medical device of claim 1, wherein the medical device is a stent, wherein the bioerodable metallic region is selected from the group consisting of magnesium, zinc, iron, calcium, alloys that comprise magnesium, alloys that comprise zinc, alloys that comprise iron, and alloys that comprise calcium, wherein the coating comprises alternating layers of phytic acid and ceramic particles and wherein the coating comprises an outer layer comprising a polymer that comprises poly(amino acid) sequence that promotes endothelial cell adhesion.

### Claim 21 (depends on 20)

The implantable or insertable medical device of claim 20, wherein said coating further comprises an antirestenotic agent or an angiogenesis inhibitor.

### Claim 22 (depends on 1)

The implantable or insertable medical device of claim 1, wherein the medical device comprises a biostable metallic substrate that comprises a first depression, wherein the first depression is at least partially filled with a first composition comprising a first therapeutic agent, wherein the bioerodable metallic region is a first bioerodable metallic layer that is disposed over the first composition, and wherein said coating is disposed over the first bioerodable metallic layer.

### Claim 23 (depends on 22)

The implantable or insertable medical device of claim 22, wherein the metallic substrate further comprises a second depression, wherein the second depression is at least partially filled with a second composition comprising a second therapeutic agent that may be the same or different from the first therapeutic agent, wherein a second bioerodable metallic layer is disposed over the second composition, wherein the second bioerodable metallic layer differs from the first bioerodable metallic layer in thickness, in composition or both, and wherein said coating is disposed over the first and second bioerodable metallic layers.

### Claim 24 (depends on 19)

The implantable or insertable medical device of claim 19 wherein said coating comprises at least three layers of said multivalent acid.

### Claim 25 (depends on 24)

The implantable or insertable medical device of claim 24, wherein the bioerodable metallic region is selected from the group consisting of magnesium and magnesium alloys.

### Claim 26 (depends on 25)

The implantable or insertable medical device of claim 25, wherein said coating comprises a reaction product of phytic acid and the underlying metallic region.

### Claim 27 (depends on 5)

The implantable or insertable medical device of claim 5, wherein the bioerodable metallic region is selected from the group consisting of magnesium and magnesium alloys.
